So-jung Gwak to Genetic Therapy
This is a "connection" page, showing publications So-jung Gwak has written about Genetic Therapy.
Connection Strength
1.805
-
Physicochemical stability and transfection efficiency of cationic amphiphilic copolymer/pDNA polyplexes for spinal cord injury repair. Sci Rep. 2017 09 12; 7(1):11247.
Score: 0.507
-
RhoA knockdown by cationic amphiphilic copolymer/siRhoA polyplexes enhances axonal regeneration in rat spinal cord injury model. Biomaterials. 2017 03; 121:155-166.
Score: 0.483
-
Therapeutic Use of 3?-[N-(N',N'-Dimethylaminoethane) Carbamoyl] Cholesterol-Modified PLGA Nanospheres as Gene Delivery Vehicles for Spinal Cord Injury. PLoS One. 2016; 11(1):e0147389.
Score: 0.453
-
Poly(lactic-co-glycolic acid) nanosphere as a vehicle for gene delivery to human cord blood-derived mesenchymal stem cells: comparison with polyethylenimine. Biotechnol Lett. 2008 Jul; 30(7):1177-82.
Score: 0.262
-
Controlled nonviral gene delivery and expression using stable neural stem cell line transfected with a hypoxia-inducible gene expression system. J Gene Med. 2010 Dec; 12(12):990-1001.
Score: 0.079
-
Hypoxia-specific VEGF-expressing neural stem cells in spinal cord injury model. Neuroreport. 2012 Feb 15; 23(3):174-8.
Score: 0.022